Call for Abstract

International Conference on Genetic Engineering & Genetically Modified Organisms, will be organized around the theme “The Power of Gene in turning Ordinary into Extraordinary”

Genetic Engineering-2013 is comprised of 18 tracks and 116 sessions designed to offer comprehensive sessions that address current issues in Genetic Engineering-2013.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Bioethics: The legal and socioeconomic impacts
  • Track 1-2Intellectual property rights
  • Track 1-3Patents & legal implications
  • Track 1-4Biodiversity and farmers rights
  • Track 2-1Biosafety regulation and national and international guidelines
  • Track 2-2r-DNA guidelines
  • Track 2-3Experimental protocol approvals, levels of containment
  • Track 2-4Roles of Institutional Biosafety Committee
  • Track 2-5Safety control of genetic modification
  • Track 3-1MACs as novel gene delivery vectors
  • Track 3-2MAC vectors for gene function studies
  • Track 3-3MAC vectors for development of animal models
  • Track 3-4Genetic defects and MAC-based therapy
  • Track 3-5MAC in stem cell research
  • Track 3-6MAC vectors for biotechnology
  • Track 3-7MACs for cancer research
  • Track 4-1Restriction and modifying enzymes
  • Track 4-2Design of linkers and adaptors
  • Track 4-3Recombinant cytokines and antibodies
  • Track 4-4Recombinant vaccines
  • Track 4-5Recombinant growth hormones
  • Track 4-6Recombinant therapeutic proteins
  • Track 4-7Biological products through genetic engineering techniques
  • Track 4-8Production of generic drugs using genetic engineering techniques
  • Track 5-1Method of production
  • Track 5-2Regulation of the release of genetic modified organisms
  • Track 5-3Genetically modified food controversies
  • Track 5-4Risk analysis and assessment
  • Track 5-5Functional food and chronic disease
  • Track 6-1Human Genome Project (HGP)
  • Track 6-2Evolutionary human genetics
  • Track 6-3Human cloning & human genetic manipulation
  • Track 6-4Genes and blood type
  • Track 6-5Genes, inheritance and evolution
  • Track 6-6Reproductive genetics
  • Track 6-7In vitro fertilization & embryo transfer technology
  • Track 6-8Genotype and phenotype
  • Track 6-9Cytogenetic and genome research
  • Track 6-10Human epigenetic disorders
  • Track 6-11Xenotransplantation & organ donation
  • Track 6-12Tissue engineering and its impacts
  • Track 7-1Isolation and purification of nucleic acids
  • Track 7-2Electrophoresis and types
  • Track 7-3Blotting and types
  • Track 7-4Polymerase Chain Reaction (PCR)
  • Track 7-5Single cell analysis: genomics and functional genomics
  • Track 7-6DNA sequencing
  • Track 7-7Preparation of probes
  • Track 7-8Different labeling methods
  • Track 7-9Hybridization and types
  • Track 7-10Radiography and chromatography techniques
  • Track 7-11Particle bombardment, electroporation & microinjection
  • Track 8-1Prokaryotic and eukaryotic gene expression
  • Track 8-2Microbial DNA: Gene transfer
  • Track 8-3Epigenetics in microorganisms
  • Track 8-4Viral genetics
  • Track 8-5Mutation: Changes to the genome
  • Track 9-1Plant genetics
  • Track 9-2Transgenic plants
  • Track 9-3Genetically modified crops & agriculture
  • Track 9-4Cloning of plant DNA & cloning vectors
  • Track 9-5Plant hormones & biotic stress
  • Track 9-6Screening and selection of mutants
  • Track 9-7Plant growth and life cycle, abiotic stress
  • Track 10-1Cell potency & toxicity screening
  • Track 10-2Preclinical and clinical research
  • Track 10-3Embryonic stem cell and adult stem cell
  • Track 10-4Induced pluripotent stem cell
  • Track 10-5Milk teeth stem cells
  • Track 10-6Menstrual blood: Rich source of stem cells
  • Track 10-7Stem cell for treating various diseases & syndromes
  • Track 11-1Vectors for cloning
  • Track 11-2Mapping the DNA and DNA finger printing
  • Track 11-3Chromosome walking and jumping
  • Track 11-4Preparation of competent cell-transformation
  • Track 11-5Gene Bank, genomic DNA library & cDNA libraries
  • Track 11-6Cloning of animals & its impact on the environment
  • Track 11-7Fish genetics
  • Track 11-8Transgenic animals
  • Track 12-1Developmental genetics
  • Track 12-2Cancer genetics
  • Track 12-3Clinical genetics
  • Track 12-4Genetic disorders and autoimmune diseases
  • Track 12-5Genetics of host response and resistance to viruses
  • Track 12-6Emerging infections & recent discoveries
  • Track 12-7Pathogen genomic biology and therapy
  • Track 13-1Vectors for gene therapy
  • Track 13-2Molecular and cell mediated gene therapy
  • Track 13-3Applications of gene therapy
  • Track 14-1Neurogenetics of Psychiatric Disorders
  • Track 14-2Clinical Neurology
  • Track 14-3Neurobehavioral Genetics
  • Track 14-4The Neurocognition of Genetic Disorders
  • Track 14-5Neural Stem Cells
  • Track 14-6Cognitive Neuroscience
  • Track 14-7Genetic Brain Disorders
  • Track 14-8Psychoneuroimmunology
  • Track 14-9Neurogenomics & disease
  • Track 15-1Insertional Mutagenesis Strategies in Cancer Genetics
  • Track 15-2Clinical Cancer Genetics
  • Track 15-3MicroRNA and Cancer
  • Track 15-4Advances in Cancer Therapy
  • Track 15-5Oncogenomics and Cancer Proteomics
  • Track 15-6Oncogene and Cancer
  • Track 15-7Role of Epigenetics in Cancer
  • Track 15-8Advancements in Bioinformatics for Cancer Research
  • Track 15-9Methods of Cancer Diagnosis, Therapy, and Prognosis
  • Track 15-10Development of New Methods for Carcinogen/Mutagen screening
  • Track 17-1Personalized Medicine
  • Track 17-2Pharmacogenomics & Pharmacokinetics
  • Track 17-3RNAi Technology: Gene knockdown for Functional Genomics
  • Track 17-4Epigenomics
  • Track 17-5Metabolomics
  • Track 17-6Predictive, Preventive and Personalised Medicine
  • Track 17-7BIOINFORMATICS & SYSTEMS BIOLOGY
  • Track 17-8EMERGING TECHNOLOGIES FOR FUNCTIONAL GENOMICS